Tag: personalized medicine in psychiatry

In a groundbreaking advance poised to reshape the therapeutic landscape for bipolar disorder, researchers have undertaken a systematic and comparative ...

Vortioxetine, an innovative pharmacological agent, has emerged as a focal point in discussions about the treatment of major depressive disorder ...

Recent advances in psychiatric medicine are shedding new light on the genetic factors that may play a crucial role in ...

In a groundbreaking convergence of psychiatric pharmacology and genomics, recent research spearheaded by Rask, Solismaa, Ahola-Olli, and colleagues has unveiled ...

Major depressive disorder (MDD) represents one of the most pervasive and debilitating mental health conditions worldwide, projected to become the ...

In a groundbreaking study that could redefine the landscape of personalized medicine in psychiatry, researchers have unveiled a novel approach ...

In the evolving landscape of psychiatric treatment, a critical dialogue has emerged surrounding the strategic and tactical application of antipsychotic ...

SALT LAKE CITY, Sept. 3, 2025 – In a significant advancement within the realm of precision psychiatry, Myriad Genetics, Inc., ...